Pipeline

Building a pipeline of unconventional T cell engagers

Engager BIO is advancing a focused pipeline with a clinical stage first generation γδ T cell engager to be tested in a rational combination therapy approach, and multiple next-generation programs designed to address unmet medical needs across patients with solid tumors and hematologic malignancies.